Insider Transactions in Q2 2021 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,500
-2.84%
|
$362,500
$29.43 P/Share
|
|
Jun 14
2021
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
4,000
-0.44%
|
$132,000
$33.33 P/Share
|
|
May 26
2021
|
Hans Hull Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+3.47%
|
$9,000
$2.08 P/Share
|
|
May 14
2021
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.38%
|
$98,000
$28.91 P/Share
|
|
Apr 14
2021
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.76%
|
$105,000
$30.33 P/Share
|
|
Apr 13
2021
|
Bernard Coulie President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+9.86%
|
$12,000
$2.08 P/Share
|